Universal Increases Quarterly Dividend From $0.80 To $0.81 Per Share

George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal Corporation (NYSE:UVV), announced today that the Company's Board of Directors declared a quarterly dividend of eighty-one cents

George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal Corporation (NYSE:UVV), announced today that the Company’s Board of Directors declared a quarterly dividend of eighty-one cents ($0.81) per share on the common shares of the Company, payable August 5, 2024, to common shareholders of record at the close of business on July 8, 2024.  This increase indicates an annualized rate of $3.24 per common share and a yield of approximately 6.08% based on the George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal Corporation (NYSE:UVV), announced today that the Company’s Board of Directors declared a quarterly dividend of eighty-one cents ($0.81) per share on the common shares of the Company, payable August 5, 2024, to common shareholders of record at the close of business on July 8, 2024.  This increase indicates an annualized rate of $3.24 per common share and a yield of approximately 6.08% based on the $53.29 closing price on May 20, 2024.$53.29 closing price on May 20, 2024.

Total
0
Shares
Related Posts
Read More

Adverum Biotechnologies Presented Nonclinical Data Sunday at the 2023 ARVO Annual Meeting Supporting Potential for Staggered Bilateral Administration of Ixo-vec

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced nonclinical data supporting the two doses of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) being evaluated in the Phase 2 LUNA trial and the potential for staggered, bilateral administration in the treatment of wet AMD.

ADVM